Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Biomedical Materials Research. Part A|May 15, 2008
Tethering a laminin peptide to a crosslinked collagen scaffold for biofunctionalityGopinath Damodaran, Russell Collighan, Martin Griffin, et al.Journal of Drug Targeting|November 12, 2010
Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosisNooshin Daneshpour, Martin Griffin, Russell Collighan, et al.European Journal of Medicinal Chemistry|July 10, 2013
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitorsEduard Badarau, Alexandre Mongeot, Russell Collighan, et al.Acta Biomaterialia|April 15, 2009
Tailored laminin-332 alpha3 sequence is tethered through an enzymatic linker to a collagen scaffold to promote cellular adhesionGopinath Damodaran, Russell Collighan, Martin Griffin, et al.The Journal of Biological Chemistry|February 28, 2002
Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretionZita Balklava, Elisabetta Verderio, Russell Collighan, et al.Journal of Biomedical Materials Research. Part A|March 7, 2013
In vivo effects of tailored laminin-332 α3 conjugated scaffolds enhances wound healing: a histomorphometric analysisGopinath Damodaran, William H C Tiong, Russell Collighan, et al.Tissue Engineering. Part A|November 4, 2008
In vitro characterization of a collagen scaffold enzymatically cross-linked with a tailored elastin-like polymerYolanda Garcia, Naik Hemantkumar, Russell Collighan, et al.Amino Acids|August 8, 2015
Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parametersRóbert Király, Kiruphagaran Thangaraju, Zsófia Nagy, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 2, 2012
Indwelling catheters and medical implants with FXIIIa inhibitors: A novel approach to the treatment of catheter and medical device-related infectionsNooshin Daneshpour, Russell Collighan, Yvonne Perrie, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2008
Synthesis of potent water-soluble tissue transglutaminase inhibitorsMartin Griffin, Alexandre Mongeot, Russell Collighan, et al.Pageof 2